Statement of Organization, Functions and Delegations of Authority, 37754 [2014-15498]
Download as PDF
<![CDATA[
37754
Federal Register / Vol. 79, No. 127 / Wednesday, July 2, 2014 / Notices
Column A—What information is requested?
Column B—put data specific to the nominated substance
Has the bulk drug substance been used previously to compound drug
product(s)?
Is there any other relevant information? ..................................................
Interested persons may submit either
electronic nominations to https://
www.regulations.gov or written
nominations to the Division of Dockets
Management (see ADDRESSES). It is only
necessary to send one set of
nominations. Identify nominations with
the docket number found in the brackets
in the heading of this document.
Received nominations may be seen in
the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday
through Friday, and will be posted to
the docket at https://
www.regulations.gov.
Dated: June 25, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–15373 Filed 7–1–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
Statement of Organization, Functions
and Delegations of Authority
This notice amends Part R of the
Statement of Organization, Functions
and Delegations of Authority of the
Department of Health and Human
Services (HHS), Health Resources and
Services Administration (HRSA) (60 FR
56605, as amended November 6, 1995;
67 FR 46519, as amended June 11, 2008;
73 FR 33099, as amended September 30,
2009, 78 FR 50227, as last amended
January 24, 2013, 78 FR 7436). This
Order of Succession supersedes the
Order of Succession for the
Administrator, HRSA, published at 78
FR 7436, February 1, 2013.
This notice deletes the Bureau of
Health Professions; the Bureau of
Clinician Recruitment and Services; and
Regional Division Directors from the
order of succession, and adds the
Bureau of Health Workforce and
Regional Administrators to HRSA’s
hierarchy affecting the Order of
Succession. This notice reflects the new
Order of Succession for HRSA.
Section R–30, Order of Succession
During the absence or disability of the
Administrator, or in the event of a
vacancy in the office, the officials
17:49 Jul 01, 2014
Jkt 232001
Provide any other information you would like FDA to consider in evaluating the nomination.
designated below shall act as
Administrator in the order in which
they are listed:
1. Deputy Administrator;
2. Chief Operating Officer;
3. Associate Administrator, Bureau of
Primary Health Care;
4. Associate Administrator, Bureau of
Health Workforce;
5. Associate Administrator, HIV/AIDS
Bureau;
6. Associate Administrator, Maternal
and Child Health Bureau;
7. Associate Administrator,
Healthcare Systems Bureau;
8. Associate Administrator, Office of
Regional Operations; and
9. HRSA Regional Administrators in
the order in which they have received
their permanent appointment as such.
Exceptions
Health Resources and Services
Administration
VerDate Mar<15>2010
Describe previous uses of the bulk drug substance in compounding.
(a) No official listed in this section
who is serving in acting or temporary
capacity shall, by virtue of so serving,
act as Administrator pursuant to this
section.
(b) Notwithstanding the provisions of
this section, during a planned period of
absence, the Administrator retains the
discretion to specify a different order of
succession.
Section R–40, Delegations of Authority
All delegations of authority and redelegations of authority made to HRSA
officials that were in effect immediately
prior to this action, and that are
consistent with this action, shall
continue in effect pending further redelegation, pending further redelegation, provided they are consistent
with this action.
This document is effective upon date
of signature.
Dated: June 25, 2014.
Mary K. Wakefield,
Administrator.
[FR Doc. 2014–15498 Filed 7–1–14; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Population
Assessment of Tobacco and Health
(PATH) Study
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institute on Drug Abuse (NIDA), the
National Institutes of Health (NIH), has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below. This proposed
information collection was previously
published in the Federal Register on
February 6, 2014, pages 7206–7207, and
allowed 60-days for public comment.
One public comment was received. The
purpose of this notice is to allow an
additional 30 days for public comment.
The National Institutes of Health may
not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_Submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project
contact: Kevin P. Conway, Ph.D.,
Deputy Director, Division of
Epidemiology, Services, and Prevention
Research, National Institute on Drug
Abuse, 6001 Executive Boulevard.,
Room 5185; or call non-toll-free number
(301)-443–8755; or Email your request,
SUMMARY:
E:\FR\FM\02JYN1.SGM
02JYN1
]]>Agencies
[Federal Register Volume 79, Number 127 (Wednesday, July 2, 2014)]
[Notices]
[Page 37754]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-15498]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Statement of Organization, Functions and Delegations of Authority
This notice amends Part R of the Statement of Organization,
Functions and Delegations of Authority of the Department of Health and
Human Services (HHS), Health Resources and Services Administration
(HRSA) (60 FR 56605, as amended November 6, 1995; 67 FR 46519, as
amended June 11, 2008; 73 FR 33099, as amended September 30, 2009, 78
FR 50227, as last amended January 24, 2013, 78 FR 7436). This Order of
Succession supersedes the Order of Succession for the Administrator,
HRSA, published at 78 FR 7436, February 1, 2013.
This notice deletes the Bureau of Health Professions; the Bureau of
Clinician Recruitment and Services; and Regional Division Directors
from the order of succession, and adds the Bureau of Health Workforce
and Regional Administrators to HRSA's hierarchy affecting the Order of
Succession. This notice reflects the new Order of Succession for HRSA.
Section R-30, Order of Succession
During the absence or disability of the Administrator, or in the
event of a vacancy in the office, the officials designated below shall
act as Administrator in the order in which they are listed:
1. Deputy Administrator;
2. Chief Operating Officer;
3. Associate Administrator, Bureau of Primary Health Care;
4. Associate Administrator, Bureau of Health Workforce;
5. Associate Administrator, HIV/AIDS Bureau;
6. Associate Administrator, Maternal and Child Health Bureau;
7. Associate Administrator, Healthcare Systems Bureau;
8. Associate Administrator, Office of Regional Operations; and
9. HRSA Regional Administrators in the order in which they have
received their permanent appointment as such.
Exceptions
(a) No official listed in this section who is serving in acting or
temporary capacity shall, by virtue of so serving, act as Administrator
pursuant to this section.
(b) Notwithstanding the provisions of this section, during a
planned period of absence, the Administrator retains the discretion to
specify a different order of succession.
Section R-40, Delegations of Authority
All delegations of authority and re-delegations of authority made
to HRSA officials that were in effect immediately prior to this action,
and that are consistent with this action, shall continue in effect
pending further re-delegation, pending further re-delegation, provided
they are consistent with this action.
This document is effective upon date of signature.
Dated: June 25, 2014.
Mary K. Wakefield,
Administrator.
[FR Doc. 2014-15498 Filed 7-1-14; 8:45 am]
BILLING CODE 4165-15-P
